期刊文献+

银丹心脑通软胶囊联合阿托伐他汀治疗高脂血症94例 被引量:3

94 Cases of Hyperlipemia Treated with Yindan Xinnaotong Soft Capsule Combined with Atorvastatin
下载PDF
导出
摘要 目的:观察银丹心脑通软胶囊联合西药阿托伐他汀治疗高脂血症的临床疗效。方法:将187例高脂血症患者随机分为对照组93例和治疗组94例。对照组患者给予西药阿托伐他汀钙片口服治疗,每次20 mg,日1次,治疗组在对照组治疗的基础上给予银丹心脑通软胶囊口服,每次3-4粒,日3次。两组均以30 d为1个疗程,治疗2个疗程后观察两组患者头晕、乏力、健忘、胸闷、心悸、肢体困重、痰多等临床症状改善情况,监测治疗前后患者的血脂总胆固醇(total cholesterol,TC)、三酰甘油(three acyl glycerin,TG)、低密度脂蛋白胆固醇(Low density lipoprotein cholesterol,LDL-C)、高密度脂蛋白胆固醇(High density lipoprotein cholesterol,HDL-C)水平。比较两组患者的有效率及胃肠道不适、肌肉酸痛等不良反应的发生率。结果:两组患者治疗后临床症状、血脂水平均较治疗前有所改善,与治疗前相比有差异性(P〈0.05)。治疗后治疗组患者TC、TG、LDL-C、HDL-C水平均低于对照组,与对照组相比,其治疗前后血脂水平变化程度更为明显(P〈0.05)。治疗组有效率为90.4%,优于对照组的73.1%(P〈0.05);两组患者不良反应发生率比较,治疗组不良反应率为9.6%,显著低于对照组的不良反应发生率24.7%(P〈0.05)。结论:银丹心脑通软胶囊联合西药阿托伐他汀能有效缓解高脂血症患者的临床症状,改善患者血脂水平,且不良反应少,具有良好的临床疗效。 Objective: To observe the clinical curative effect of Yindan Xinnaotong Soft Capsule(银丹心脑通软胶囊,YDXNTSC) combined with atorvastatin on hyperlipemia.Methods: 187 patients with hyperlipemia were randomly divided into the control group with 93 cases and the treatment group with 94 cases.The patients in the control group were given atorvastatin calcium tablet for oral administration,20 mg each time,once a day.Based on this treatment,the ones in the treatment group were added YDXNTSC for oral administration,3-4 granules each time,3 times a day.Both groups regarded 30 days as a treatment course.After 2 courses,in both groups,patients' clinical symptoms improvement such as dizziness,fatigue,amnesia,chest distress,palpitation,drowsy heaviness of limbs and excessive phlegm were observed; The levels of patients ' blood fat total cholesterol(BFTC),three acyl glycerin(TG),low density lipoprotein cholesterol(LDL-C),high density lipoprotein cholesterol(HDL-C)were tested; The effective rate,the occurrence rate of adverse reactions such as discomfort of gastrointestinal tract and aching pain of muscles,etc.were compared.Results: After the treatment,both groups' clinical symptoms and blood fat level were improved,and there was difference between before and after the treatment(P〈0.05).After the treatment,the levels of TC、TG、LDL-C、HDL-C of the treatment group were all lower than those of the control group; And compared with the control group,the change of blood fat level of the treatment group was more obvious(P〈0.05).The effective rate of the treatment group(90.4%)was superior to that(73.1%) of the control group(P〈0.05).The adverse reaction occurrence rate of the treatment group(9.6%) was much lower than that(24.7%) of the control group(P〈0.05).Conclusion: YDXNTSC combined with atorvastatin can effectively release the clinical symptoms of patients with hyperlipemia,improve their blood fat level,and has very good curative effect with few adverse reactions.
出处 《河南中医》 2015年第3期612-614,共3页 Henan Traditional Chinese Medicine
关键词 高脂血症 银丹心脑通软胶囊 阿托伐他汀 血脂总胆固醇 三酰甘油 低密度脂蛋白胆固醇 高密度脂蛋白胆固醇 hyperlipemia Yindan Xinnaotong Soft Capsule atorvastatin blood fat total cholesterol(BFTC) three acyl glycerin(TG) low density lipoprotein cholesterol(LDL-C) high density lipoprotein cholesterol(HDL-C)
  • 相关文献

参考文献13

  • 1Zhang X,Patel A,Horibe H,et al.Cholesterol,coronary heart disease,and stroke in the Asia Pacific region[J].Int J Epidemiol,2003,32(4):563-572.
  • 2中国成人血脂异常防治委员会.中国成人血脂异常防治指南[S].北京:人民卫生出版社,2007:6.
  • 3国家食品药品监督局.中药新药临床研究指导原则:试行[S].北京:中国医药科技出版社,2002:85-89.
  • 4袁如彩,邵珠民,姬怀雪,王福贵,邵茜.HPLC法同时测定复方阿托伐他汀钙分散片中2组分含量[J].中国药房,2011,22(37):3521-3523. 被引量:5
  • 5徐风玲.化浊祛痰活血汤治疗高脂血症70例[J].河南中医,2012,32(10):1330-1331. 被引量:3
  • 6牛颖,姚娜,郭向东.丹蒌片治疗高脂血症30例[J].河南中医,2013,33(11):1911-1912. 被引量:11
  • 7Robinson JG,Smith B,Maheshwari N,et al.Pleiotropic effects of statins:benefit beyond cholesterol reduction A meta-regression analysis[J].J Am Coll Cardiol,2005,46(5):1855-1862.
  • 8European Association for Cardiovascular Prevention&Rehabilitation,Reiner Z,Catapano AL,et al.ESC/EAS Guidelines for the management of dyslipidaemias:the Task Force for the management of dyslipidaemias of the European Society of Cardiology(ESC)and the European Atherosclerosis Society(EAS)[J].Eur Heart J,2011,32(11):1769-1818.
  • 9Mc Kenney JM.Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering:benefits versusrisks[J].Am J Cardiol,2005,96(4):60-66.
  • 10王利军,罗五金,张新平.国内阿托伐他汀治疗高脂血症有效性和安全性的Meta分析[J].医药导报,2013,32(11):1443-1450. 被引量:11

二级参考文献113

共引文献96

同被引文献41

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部